Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
(Source: Trials)
Source: Trials - February 15, 2022 Category: Research Source Type: clinical trials

Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
Condition:   Influenza Interventions:   Drug: Baloxavir Marboxil;   Drug: Placebo;   Drug: Oseltamivir Sponsors:   Weill Medical College of Cornell University;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials

Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir
Condition:   Drug-drug Interaction Interventions:   Drug: ZSP1273;   Drug: Oseltamivir Sponsor:   Guangdong Raynovent Biotech Co., Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2021 Category: Research Source Type: clinical trials